Anti-A, Anti-B, Anti-D IgM+IgG Reagent Combipack for Routine Blood Grouping and Typing
- UID
- MFG/IVD/2021/000021_e796e28090c4e156ff01419c240e8dbc_25a109280f502ac96adedf402c283765
- Device class
- Class D
- Brand name
- RPR
- License holder
- TULIP DIAGNOSTICS PRIVATE LIMITED
- Approving authority
- Sub Zonal Goa
- Product information
- Eryscreen Plus is a reagent combipack for ABO grouping, Rho (RPR) typing and confirmation by slide or tube test and is 100% specific to A1, A2, Ax, B, negative reacting with Acquired B characteristics, A & B antigen and Rho(RPR) antigens
Anti-A, Anti-B, Anti-D IgM+IgG Reagent Combipack for Routine Blood Grouping and Typing is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000021_e796e28090c4e156ff01419c240e8dbc_25a109280f502ac96adedf402c283765. This device is marketed under the brand name RPR. The license holder is TULIP DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class D. The approving authority is Sub Zonal Goa.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.